The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study

[Display omitted] •Previous studies and meta-analysis have suggested the possible existence of sex-related differences in response to immunotherapy.•We conducted a meta-analysis aimed at systematically exploring the presence of sex-related differences in patients treated with ICI.•This study is the...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Critical reviews in oncology/hematology Ročník 170; s. 103596
Hlavní autori:	Santoni, Matteo, Rizzo, Alessandro, Mollica, Veronica, Matrana, Marc R., Rosellini, Matteo, Faloppi, Luca, Marchetti, Andrea, Battelli, Nicola, Massari, Francesco
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier B.V 01.02.2022
Predmet:	Atezolizumab Avelumab Durvalumab Female Gender Humans Immune Checkpoint Inhibitors Immunotherapy Lung Neoplasms - drug therapy Male Neoplasms - drug therapy Nivolumab Pembrolizumab Sex Pembrolizumab Durvalumab Nivolumab Immunotherapy Sex Avelumab Gender Atezolizumab
ISSN:	1040-8428, 1879-0461, 1879-0461
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!